LIVANOVA PLC (LIVN) Stock Fundamental Analysis

NASDAQ:LIVN • GB00BYMT0J19

69.05 USD
+0.7 (+1.02%)
At close: Feb 24, 2026
69.05 USD
0 (0%)
After Hours: 2/24/2026, 4:04:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, LIVN scores 5 out of 10 in our fundamental rating. LIVN was compared to 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of LIVN get a neutral evaluation. Nothing too spectacular is happening here. LIVN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year LIVN was profitable.
  • In the past year LIVN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
  • LIVN had a positive operating cash flow in 4 of the past 5 years.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • LIVN's Return On Assets of -8.50% is fine compared to the rest of the industry. LIVN outperforms 63.78% of its industry peers.
  • With a decent Return On Equity value of -18.78%, LIVN is doing good in the industry, outperforming 61.08% of the companies in the same industry.
  • LIVN's Return On Invested Capital of 8.35% is amongst the best of the industry. LIVN outperforms 84.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 8.75%.
  • The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.5%
ROE -18.78%
ROIC 8.35%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • With an excellent Operating Margin value of 14.94%, LIVN belongs to the best of the industry, outperforming 82.70% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LIVN has grown nicely.
  • LIVN has a better Gross Margin (68.50%) than 75.14% of its industry peers.
  • In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 14.94%
PM (TTM) N/A
GM 68.5%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LIVN is destroying value.
  • The number of shares outstanding for LIVN has been increased compared to 1 year ago.
  • The number of shares outstanding for LIVN has been increased compared to 5 years ago.
  • LIVN has a worse debt/assets ratio than last year.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.87 indicates that LIVN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.87, LIVN perfoms like the industry average, outperforming 58.38% of the companies in the same industry.
  • The Debt to FCF ratio of LIVN is 2.26, which is a good value as it means it would take LIVN, 2.26 years of fcf income to pay off all of its debts.
  • LIVN's Debt to FCF ratio of 2.26 is amongst the best of the industry. LIVN outperforms 85.95% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that LIVN is not too dependend on debt financing.
  • LIVN has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Altman-Z 1.87
ROIC/WACC0.96
WACC8.67%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • LIVN has a Current Ratio of 1.33. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN has a Current ratio of 1.33. This is in the lower half of the industry: LIVN underperforms 78.38% of its industry peers.
  • LIVN has a Quick Ratio of 1.12. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN has a worse Quick ratio (1.12) than 73.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.12
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
  • Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
  • The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.20% on average over the next years. This is quite good.
  • Based on estimates for the next years, LIVN will show a small growth in Revenue. The Revenue will grow by 6.85% on average per year.
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y6.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.94, the valuation of LIVN can be described as rather expensive.
  • Based on the Price/Earnings ratio, LIVN is valued cheaper than 85.95% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of LIVN to the average of the S&P500 Index (26.64), we can say LIVN is valued slightly cheaper.
  • LIVN is valuated correctly with a Price/Forward Earnings ratio of 16.38.
  • LIVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 87.03% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, LIVN is valued a bit cheaper.
Industry RankSector Rank
PE 17.94
Fwd PE 16.38
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • LIVN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LIVN is cheaper than 83.24% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, LIVN is valued cheaper than 91.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.63
EV/EBITDA 14.31
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.06
PEG (5Y)9.88
EPS Next 2Y11.85%
EPS Next 3Y10.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVANOVA PLC

NASDAQ:LIVN (2/24/2026, 4:04:03 PM)

After market: 69.05 0 (0%)

69.05

+0.7 (+1.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners105.72%
Inst Owner Change-2.18%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.77B
Revenue(TTM)1.35B
Net Income(TTM)-217.38M
Analysts82.35
Price Target73.19 (6%)
Short Float %4.48%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)0.25%
PT rev (3m)6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 17.94
Fwd PE 16.38
P/S 2.8
P/FCF 19.63
P/OCF 15.03
P/B 3.26
P/tB 28.64
EV/EBITDA 14.31
EPS(TTM)3.85
EY5.58%
EPS(NY)4.22
Fwd EY6.11%
FCF(TTM)3.52
FCFY5.1%
OCF(TTM)4.6
OCFY6.65%
SpS24.7
BVpS21.19
TBVpS2.41
PEG (NY)1.06
PEG (5Y)9.88
Graham Number42.84
Profitability
Industry RankSector Rank
ROA -8.5%
ROE -18.78%
ROCE 11.65%
ROIC 8.35%
ROICexc 13.32%
ROICexgc 247.44%
OM 14.94%
PM (TTM) N/A
GM 68.5%
FCFM 14.24%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Debt/EBITDA 1.42
Cap/Depr 132.33%
Cap/Sales 4.36%
Interest Coverage 250
Cash Conversion 102%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.12
Altman-Z 1.87
F-Score6
WACC8.67%
ROIC/WACC0.96
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y6.85%
EBIT growth 1Y50.76%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year41.25%
EBIT Next 3Y18.09%
EBIT Next 5Y3.36%
FCF growth 1Y2170.19%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y532.75%
OCF growth 3Y21.3%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.86% in the next year.